{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T14:16:04Z","timestamp":1791728164200,"version":"4.3.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Qual Life Outcomes"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Sapropterin dihydrochloride effectively lowers plasma phenylalanine (Phe) for at least a third of phenylketonuria (PKU) patients, with potential for increased dietary Phe tolerance and decreased medical food requirement.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>To investigate long-term quality of life (QOL) in patients with phenylketonuria (PKU) who took sapropterin (BH4, Kuvan\u00ae) for up to one year.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>37 PKU patients, ages 10\u201349\u00a0years, were asked to complete a PKU-specific self-report QOL questionnaire (QOLQ) at baseline, 1, 4, 8, and 12 months. Questions were scored on a 5-point Likert scale under 5 sub-sections measuring Impact, Worries, Satisfaction, Support, and General wellbeing in relation to PKU. Responders with a plasma Phe decrease\u2009\u2265\u200915% after 1 month on sapropterin remained on the drug; Nonresponders ceased sapropterin after the trial month. Responders able to relax medical diet and maintain plasma Phe control were classified as Definitive; Responders unable to relax medical diet were classified as Provisional. All patients were routinely monitored by a registered dietitian. Data was analyzed in SPSS 19.0 using regression techniques.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Of 17 Responders, 11 could maintain adequate Phe control on a less restrictive diet. One year mean Impact sub-score trends improved significantly for all sapropterin response groups, with greatest improvement among Definitive Responders (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001). Satisfaction sub-scores also improved for Definitive Responders (<jats:italic>p<\/jats:italic>\u2009=\u20090.001). Trends for Total QOL score improved significantly over time for both Definitive (<jats:italic>p<\/jats:italic>\u2009=\u20090.001) and Provisional Responders (<jats:italic>p<\/jats:italic>\u2009=\u20090.028). Improvements in Definitive Responder scores were associated with increased Phe tolerance (Impact: <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001, Satisfaction: <jats:italic>p<\/jats:italic>\u2009=\u20090.022, Total QOL: <jats:italic>p<\/jats:italic>\u2009=\u20090.005) and MF adjustment (Satisfaction: <jats:italic>p<\/jats:italic>\u2009=\u20090.014, Total QOL: <jats:italic>p<\/jats:italic>\u2009=\u20090.026). Other sub-section scores remained steady, unaffected by sapropterin response or diet modification.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Increased Phe tolerance and reduced MF requirement in sapropterin Definitive Responders improves QOL perception across one year, specifically for life impact and satisfaction.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1477-7525-11-218","type":"journal-article","created":{"date-parts":[[2013,12,30]],"date-time":"2013-12-30T08:01:23Z","timestamp":1388390483000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Longitudinal quality of life analysis in a phenylketonuria cohort provided sapropterin dihydrochloride"],"prefix":"10.1186","volume":"11","author":[{"given":"Teresa D","family":"Douglas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usha","family":"Ramakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A","family":"Kable","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rani H","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,30]]},"reference":[{"key":"1255_CR1","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s10545-005-4478-8","volume":"28","author":"C Bilginsoy","year":"2005","unstructured":"Bilginsoy C, et al.: Living with phenylketonuria: Perspectives of patients and their families. J Inherit Metab Dis 2005, 28: 639\u2013649.","journal-title":"J Inherit Metab Dis"},{"key":"1255_CR2","first-page":"U2728","volume":"120","author":"FF Legge","year":"2007","unstructured":"Legge FF: Phenylketonuria\u2013the lived experience. J New Zealand Med Assoc 2007, 120: U2728.","journal-title":"J New Zealand Med Assoc"},{"key":"1255_CR3","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/j.1365-277X.2008.00879.x","volume":"21","author":"SJ Durham-Shearer","year":"2008","unstructured":"Durham-Shearer SJ, Judd PA, Whelan K, Thomas JE: Knowledge, compliance and serum phenylalanine concentrations in adolescents and adults with phenylketonuria and the effect of a patient-focused educational resource. J Hum Nutr Diet 2008, 21: 474\u2013485.","journal-title":"J Hum Nutr Diet"},{"key":"1255_CR4","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1007\/s10545-007-0602-2","volume":"30","author":"K Aoki","year":"2007","unstructured":"Aoki K, Ohwada M, Kitagawa T: Long-term follow-up study of patients with phenylketonuria detected by the newborn screening programme in Japan. J Inherit Metab Dis 2007, 30: 608\u2013608.","journal-title":"J Inherit Metab Dis"},{"key":"1255_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ymgme.2012.11.003","volume":"108","author":"BK Burton","year":"2013","unstructured":"Burton BK, et al.: A diversified approach for PKU treatment: Routine screening yields high incidence of psychiatric distress in phenylketonuria clinics. Mol Genet Metab 2013, 108: 8\u201312.","journal-title":"Mol Genet Metab"},{"key":"1255_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1023\/B:BOLI.0000028725.37345.62","volume":"27","author":"GL Arnold","year":"2004","unstructured":"Arnold GL, et al.: Prevalence of stimulant use for attentional dysfunction in children with phenylketonuria. J Inherit Metab Dis 2004, 27: 137\u2013143.","journal-title":"J Inherit Metab Dis"},{"key":"1255_CR7","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/BF01953938","volume":"155","author":"J Weglage","year":"1996","unstructured":"Weglage J, et al.: Deficits in selective and sustained attention processes in early treated children with phenylketonuria\u2013result of impaired frontal lobe functions? Eur J Pediatr 1996, 155: 200\u2013204.","journal-title":"Eur J Pediatr"},{"key":"1255_CR8","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1399-0004.2008.01101.x","volume":"75","author":"R Sharman","year":"2009","unstructured":"Sharman R, Sullivan K, Young R, McGill J: Biochemical markers associated with executive function in adolescents with early and continuously treated phenylketonuria. Clin Genet 2009, 75: 169\u2013174.","journal-title":"Clin Genet"},{"key":"1255_CR9","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s00787-009-0738-8","volume":"18","author":"B Azadi","year":"2009","unstructured":"Azadi B, et al.: Executive dysfunction in treated phenylketonuric patients. Eur Child Adolesc Psychiatry 2009, 18: 360\u2013368.","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"1255_CR10","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1207\/s15326942dn3003_5","volume":"30","author":"SE Christ","year":"2006","unstructured":"Christ SE, et al.: Inhibitory control in children with phenylketonuria. Dev Neuropsychol 2006, 30: 845\u2013864.","journal-title":"Dev Neuropsychol"},{"key":"1255_CR11","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1023\/A:1005669610722","volume":"23","author":"BA Stemerdink","year":"2000","unstructured":"Stemerdink BA, et al.: Behaviour and school achievement in patients with early and continuously treated phenylketonuria. J Inherit Metab Dis 2000, 23: 548\u2013562.","journal-title":"J Inherit Metab Dis"},{"key":"1255_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1477-7525-6-25","volume":"6","author":"E Simon","year":"2008","unstructured":"Simon E, et al.: Evaluation of quality of life and description of the sociodemographic state in adolescent and young adult patients with phenylketonuria (PKU). Health Qual Life Outcomes 2008, 6: 25.","journal-title":"Health Qual Life Outcomes"},{"issue":"Suppl 2","key":"1255_CR13","doi-asserted-by":"publisher","first-page":"S415","DOI":"10.1007\/s10545-008-0978-7","volume":"31","author":"M Bik-Multanowski","year":"2008","unstructured":"Bik-Multanowski M, et al.: Quality of life in noncompliant adults with phenylketonuria after resumption of the diet. J Inherit Metab Dis 2008,31(Suppl 2):S415-S418.","journal-title":"J Inherit Metab Dis"},{"key":"1255_CR14","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1111\/j.1651-2227.2003.tb00834.x","volume":"92","author":"R Gassio","year":"2003","unstructured":"Gassio R, et al.: Do adult patients with phenylketonuria improve their quality of life after introduction\/resumption of a phenylalanine-restricted diet? Acta Paediatr 2003, 92: 1474\u20131478.","journal-title":"Acta Paediatr"},{"key":"1255_CR15","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ymgme.2011.10.014","volume":"105","author":"JR Utz","year":"2012","unstructured":"Utz JR, et al.: START, a double blind, placebo-controlled pharmacogenetic test of responsiveness to sapropterin dihydrochloride in phenylketonuria patients. Mol Genet Metab 2012, 105: 193\u2013197.","journal-title":"Mol Genet Metab"},{"key":"1255_CR16","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.ymgme.2011.09.009","volume":"104","author":"RH Singh","year":"2011","unstructured":"Singh RH, Quirk ME: Using change in plasma phenylalanine concentrations and ability to liberalize diet to classify responsiveness to tetrahydrobiopterin therapy in patients with phenylketonuria. Mol Genet Metab 2011, 104: 485\u2013491.","journal-title":"Mol Genet Metab"},{"key":"1255_CR17","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1177\/014572179101700219","volume":"17","author":"M Ingersoll","year":"1991","unstructured":"Ingersoll M: A modified quality-of-life measure for youths: psychometric properties. Diabetes Educ 1991, 17: 114\u2013118.","journal-title":"Diabetes Educ"},{"key":"1255_CR18","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S0002-8223(00)00232-7","volume":"100","author":"RH Singh","year":"2000","unstructured":"Singh RH, et al.: Impact of a Camp Experience on Phenylalanine Levels, Knowledge, Attitudes, and Health Beliefs Relevant to Nutrition Management of Phenylketonuria in Adolescent Girls. J Am Diet Assoc 2000, 100: 797\u2013803.","journal-title":"J Am Diet Assoc"},{"key":"1255_CR19","volume-title":"Statistical Power Analysis for the Behavioral Sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J, Cohen P, West SG, Aiken LS: Statistical Power Analysis for the Behavioral Sciences. 2nd edition. Hillsdale, NJ: Lawrence Earlbaum Associates; 1988.","edition":"2"},{"key":"1255_CR20","first-page":"343","volume-title":"G.A. Marcoulides","author":"SLT RH Heck","year":"2010","unstructured":"RH Heck SLT, Tabata LN, Heck RH SLT, Tabata LN: Multilevel and longitudinal modeling with IBM SPSS. In G.A. Marcoulides. 1st edition. Edited by: Quantitative Methodology Series. New York: Routledge; 2010:343.","edition":"1"},{"key":"1255_CR21","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1111\/j.1651-2227.2011.02227.x","volume":"100","author":"G Cotugno","year":"2011","unstructured":"Cotugno G, et al.: Adherence to diet and quality of life in patients with phenylketonuria. Acta Paediatr 2011, 100: 1144\u20131149.","journal-title":"Acta Paediatr"},{"key":"1255_CR22","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s10545-012-9458-1","volume":"35","author":"B Ziesch","year":"2012","unstructured":"Ziesch B, et al.: Tetrahydrobiopterin (BH(4)) in PKU: effect on dietary treatment, metabolic control, and quality of life. J Inherit Metab Dis 2012, 35: 983\u2013992.","journal-title":"J Inherit Metab Dis"},{"key":"1255_CR23","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1007\/s10545-009-1253-2","volume":"32","author":"AM Bosch","year":"2009","unstructured":"Bosch AM, et al.: Remarkable differences: the course of life of young adults with galactosaemia and PKU. J Inherit Metab Dis 2009, 32: 706\u2013712.","journal-title":"J Inherit Metab Dis"},{"key":"1255_CR24","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1067\/mpd.2002.123663","volume":"140","author":"MA Landolt","year":"2002","unstructured":"Landolt MA, et al.: Quality of life and psychologic adjustment in children and adolescents with early treated phenylketonuria can be normal. J Pediatr 2002, 140: 516\u2013521.","journal-title":"J Pediatr"},{"key":"1255_CR25","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.otohns.2008.05.026","volume":"139","author":"CG Gourin","year":"2008","unstructured":"Gourin CG: Quality of life is more than the sum of its parts. Otolaryngol Head Neck Surg 2008, 139: 273\u2013274.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"1255_CR26","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1097\/MLR.0b013e31814848f1","volume":"45","author":"DG Fryback","year":"2007","unstructured":"Fryback DG, et al.: US norms for six generic health-related quality-of-life indexes from the National Health Measurement study. Med Care 2007, 45: 1162\u20131170.","journal-title":"Med Care"},{"key":"1255_CR27","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1177\/0272989X06290497","volume":"26","author":"J Hanmer","year":"2006","unstructured":"Hanmer J, et al.: Report of nationally representative values for the noninstitutionalized US adult population for 7 health-related quality-of-life scores. Med Decis Making 2006, 26: 391\u2013400.","journal-title":"Med Decis Making"},{"key":"1255_CR28","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s00431-005-1681-4","volume":"164","author":"VM Wagner","year":"2005","unstructured":"Wagner VM, et al.: Age, metabolic control and type of insulin regime influences health-related quality of life in children and adolescents with type 1 diabetes mellitus. Eur J Pediatr 2005, 164: 491\u2013496.","journal-title":"Eur J Pediatr"}],"container-title":["Health and Quality of Life Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7525-11-218.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T02:30:57Z","timestamp":1630549857000},"score":1,"resource":{"primary":{"URL":"https:\/\/hqlo.biomedcentral.com\/articles\/10.1186\/1477-7525-11-218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1255"],"URL":"https:\/\/doi.org\/10.1186\/1477-7525-11-218","relation":{},"ISSN":["1477-7525"],"issn-type":[{"value":"1477-7525","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"21 August 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"218"}}